Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
UC Davis Health, Department of Pediatrics
2516 Stockton Blvd.Sacramento, California, United States
Phone Web
The Section of Pediatric Hematology/Oncology cares for infants, children, and adolescents diagnosed with blood disorders and malignant diseases. The Section is dedicated to addressing all issues involved in caring for these patients in a comprehensive manner.
The primary nonmalignant disorders include patients with Sickle Cell Anemia, Thalassemia, bleeding and other blood clotting diseases, and patients with platelet dysfunctions. The Pediatric Comprehensive Hemoglobinopathy Clinic is a State of California center-designated program and provides expertise for children with red blood cell disorders. Currently, the clinic serves 150 children and adolescents from the Sacramento and Northern California areas. While most of these children have been diagnosed with Sickle Cell Anemia, approximately 40 have thalassemia disorders, which is particularly common amongst the Southeast Asian population. Children with blood clotting disorders are cared for in the state center-designated Hemophilia Program. The program is dedicated to the evaluation and care of children and adolescents, as well as clinical research related to all aspects of hemophilia. The Center currently serves about 300 patients.
Related Content
-
Provider Perspectives of Necessary Factors in Sickle Cell Disease Health Care Transition: Results from an Online Sur...Introduction: Survivorship of children w...
-
The Association Between Timely Opioid Administration and Hospitalization in Children With Sickle Cell Disease Presen...Objective: To evaluate the association ...
-
Adult Sickle Cell Clinic at UAMSThe University of Arkansas for Medical S...
-
Ginna Priola, MDGinna Priola is a pediatric hematologist...
-
Steven Ambrusko, MD, MSDr. Ambrusko is a pediatric hematologist...
-
Sickle Cell Disease Association of America Michigan Chapter, Inc.The vision of Sickle Cell Disease Associ...
-
FDA Approves Novel Treatment to Target Abnormality in Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
+myBinder